Primary Central Nervous System Post-Transplantation Lymphoproliferative Disorder: An International Primary Central Nervous System Lymphoma Collaborative Group Report

Por Cavaliere, Robert, Petroni, Gina, Lopes, Maria B., Schiff, David
Publicado em 2010

A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanoma

Por Wages, Nolan A., Slingluff, Craig L., Petroni, Gina R.
Publicado no Contemp Clin Trials (2015)

A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial

Por Wages, Nolan A., Read, Paul W., Petroni, Gina R.
Publicado no Pharm Stat (2015)

Implementation of adaptive methods in early-phase clinical trials

Por Petroni, Gina R., Wages, Nolan A., Paux, Gautier, Dubois, Frédéric
Publicado no Stat Med (2016)

INFRARED THERMOGRAPHY OF CUTANEOUS MELANOMA METASTASES

Por Shada, Amber L., Dengel, Lynn T., Petroni, Gina R., Smolkin, Mark E., Acton, Scott, Slingluff, Craig L.
Publicado no J Surg Res (2012)

Total body photography for skin cancer screening

Por Dengel, Lynn T., Petroni, Gina R., Judge, Joshua, Chen, David, Acton, Scott T., Schroen, Anneke T., Slingluff, Craig L
Publicado no Int J Dermatol (2014)

Inflammatory Adverse Events are Associated with Disease-Free Survival after Vaccine Therapy among Patients with Melanoma

Por Hu, Yinin, Smolkin, Mark E., White, Emily J., Petroni, Gina R., Neese, Patrice Y., Slingluff, Craig L.
Publicado em 2014

Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer

Por Smith, Philip W., Liu, Yuan, Siefert, Suzanne A., Moskaluk, Christopher A., Petroni, Gina R., Jones, David R.
Publicado no Cancer Lett (2008)

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable...

Por Katz, Matthew, Todd, Bauer W, Varadhachary, Gauri, Acquavella, Nicolas, Petroni, Gina, Bullock, Timothy, Slingluff, Craig L, Rahma, Osama
Publicado no J Immunother Cancer (2015)

Accelerated Fraction Radiotherapy With Capecitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

Por Chakraborty, Samhita, Morris, Monica M., Bauer, Todd W., Adams, Reid B., Stelow, Edward B., Petroni, Gina, Sanoff, Hanna K.
Publicado em 2014

Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices

Por Harvey, Jennifer A., Santen, Richard J., Petroni, Gina R., Bovbjerg, Viktor E., Smolkin, Mark E., Sheriff, Fathima S., Russo, Jose
Publicado no Menopause (2008)

Mesothelium expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC)

Por Scalici, Jennifer M., Arapovic, Sanja, Saks, Erin, Atkins, Kristen A., Petroni, Gina, Duska, Linda R., Slack-Davis, Jill K.
Publicado no Cancer (2016)

Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis

Por Schaefer , Jochen T, Patterson , James W, Deacon , Donna H, Smolkin, Mark E, Petroni , Gina R, Jackson , Emily M, Slingluff, Craig L
Publicado em 2010

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer

Por Hollen, Patricia J., Gralla, Richard J., Jones, Randy A., Thomas, Christopher Y., Brenin, David R., Weiss, Geoffrey R., Schroen, Anneke T., Petroni, Gina R.
Publicado em 2012

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine

Por Hu, Yinin, Petroni, Gina R., Olson, Walter C., Czarkowski, Andrea, Smolkin, Mark E., Grosh, William W., Chianese-Bullock, Kimberly A., Slingluff, Craig L.
Publicado em 2014

Immunologic hierarchy and promiscuity of melanoma helper peptides

Por Hu, Yinin, Petroni, Gina R, Olson, Walter C, Czarkowski, Andrea, Smolkin, Mark, Grosh, William W, Rehm, Patrice K, Murphy, Cheryl F, Coleman, Elizabeth J
Publicado em 2013

Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine

Por Slingluff, Craig L., Petroni, Gina R., Chianese-Bullock, Kimberly A., Smolkin, Mark E., Ross, Merrick I., Haas, Naomi B., von Mehren, Margaret, Grosh, William W.
Publicado em 2011

Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide

Por Salerno, Elise P., Shea, Sofia M., Olson, Walter C., Petroni, Gina R., Smolkin, Mark E., McSkimming, Chantel, Chianese-Bullock, Kimberly A., Slingluff, Craig L.
Publicado em 2013

Intraoperative Imaging Guidance for Sentinel Node Biopsy in Melanoma Using a Mobile Gamma Camera

Por Dengel, Lynn T., More, Mitali J., Judy, Patricia G., Petroni, Gina R., Smolkin, Mark E., Rehm, Patrice K., Majewski, Stan, Williams, Mark B., Slingluff, Craig L.
Publicado no Ann Surg (2011)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

Por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado em 2013